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Introduction
Mitochondrial dysfunction (bioenergetic failure) is
knownt to contribute to the development of multiorgan
failure in acute sepsis. The defect is mainly at the level
of respiratory complex I [1,2].
Objectives
To assess whether mitochondrial dysfunction in skeletal
muscle perists until protracted critical illness and whether
it contributes to the development of ICU-acquired
weakness.
Methods
Muscle biopsies were obtained from critically ill patients
with severe ICUAW (defined as MRC score < 24 on two
separate tests) and from otherwise healthy controls under-
going elective hip replacement. 50-100mg of the native
sample was homogenized by a technique which perserves
mitochondria in their cytosolic context [3]. Oxygen con-
sumption was measured by high-resolution respirometry
(Oxygraph-2Km Oroboros) under two occasions: 1. homo-
genate enriched with substrates was sequentially treated
with an ATPase inhibitor (oligomycine), an uncoupler
(FCCP) and KCN. This allowed us to measure oxidative
phosphorylation, respiratory chain capacity, proton leak
through inner mitochondrial membrane and non-mito-
chondrial O2 consumption. 2. skeletal muscle homogenate
enriched with abundant ADP was treated with sequential
addition of substrates and inhibitors of complexes I, II, III,
and IV, respectively. Integrity of outer membrane was
assessed by measuring the response to addition of cyto-
chrome c. Oxygen consumption rate was normalized to
citrate-synthase activity and total protein content.
Results
In skeletal muscle of patients with protracted critical ill-
ness and severe ICUAW we have found the activity of
complex II and III to be >200% of activity of healthy con-
trols. Function of complexes I and IV was identical as
were global mitochondrial function/integrity indices.
Upregulation of complex II may represent an adaptive
phenomenon as skeletal muscle during critical illness is
more reliant on fatty oxidation (which feeds electrons to
respiratory chain via complex II), because of insulin
resistance and impaired oxidative glucose disposal.
Conclusions
In patients with severe ICUAW we have demonstrated
increased activity of respiratory chain complexes down-
stream to complex I and intact global mitochondrial
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Table 1 Activities of respiratory complexes [pmol/nkat]
Data as median (IQR) Complex I Complex II Complex III Complex IV Leak Resp. chain spare capacity
ICUAW (n=6) 22 (16-23) 23 (20-28) 7 (4-8) 67 (62-93) 7 (5-11) 43 (40-46)
Controls (n=5) 21 (20-25) 9 (3-19) 3 (2-4) 59 (42-109) 8 (5-10) 45 (36-73)
p [Mann Whitney 0.860 0.045 0.028 0.715 0.806 0.724
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function. This may represent an adaptation to insulin
resistance.
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